The molecular and cellular mechanisms that generate the T h 2 cytokine environment necessary for the maintenance of pregnancy are still not fully understood. We herein show that the human decidua is highly enriched for TCRab 1 CD161
Introduction
Allogeneic tissue grafts are typically rejected by immune responses directed against non-self-MHC. In contrast, the fetus, which resembles a semi-allogeneic graft, is accepted by the maternal immune system. Although the T h 2-type environment have been suggested to be a pivotal condition that permit the genetically distinct fetus to survive and develop within the mother, the precise cellular and molecular mechanisms underlying the maintenance of pregnancy and the induction of abortion remain unclear (1) (2) (3) (4) .
Several specialized mechanisms have evolved to help the fetus evade maternal immune attack. The fetal trophoblast cells that invade maternal uterine tissue at the site of implantation lack the surface expression of HLA-A and HLA-B antigens (5, 6) , but selectively express HLA-C and nonclassical HLA-E and HLA-G (7) (8) (9) . They inhibit the cytolytic activity of NK cells through interaction with inhibitory receptors, namely Ig-like killer cell inhibitory receptor (KIR) and lectin-like KIRs (10) (11) (12) . In addition, the expression of Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by trophoblast cells may cause apoptosis of activated maternal T cells, which express Fas or TRAILR, respectively (13, 14) . Moreover, the maternal CD4 + CD25 + regulatory T cells are expanded and play an important role for the suppression of maternal immune response directed against the fetus (15) . The indoleamine 2,3-deoxygenase, an enzyme that catabolizes tryptophan, indirectly suppresses maternal T cell activity by tryptophan deprivation (16) .
Recently, the expression of CD1d molecules on villous and extravillous trophoblast cells has been reported (17) . The CD1d molecule is specialized in the presentation of a limited set of glycolipids for recognition by NKT cells, a unique T cell subset expressing both TCRs and NK cell receptors (18) . The placenta and the amnion are highly enriched for glycosphingolipids, many of which are sialic acid-containing gangliosides (19) (20) (21) (22) that may be presented by CD1 and recognized by NKT cells (23) (24) (25) . It is therefore important to elucidate the roles of CD1-restricted NKT cells that reside at the maternal-fetal interface during pregnancy. The most characterized NKT subset expresses an invariant TCRa chain (Va14-Ja281 in mice and Va24-JaQ in humans), recognizes a synthetic glycolipid, a-galactosylceramide (aGalCer), and is referred to as invariant NKT (iNKT) cells (26) . In addition to the iNKT cells, a population of CD1d-restricted NKT cells that express diverse TCRs, referred to non-invariant NKT (non-iNKT) cells, have also been described (27, 28) . In humans, non-iNKT cells have recently been characterized in the bone marrow and hepatitis C virus-infected liver (29, 30) . The former is strongly T h 2 biased whereas the latter is T h 1 like, indicating that organspecific mechanisms might dictate the functional capabilities of resident NKT cells. Although the iNKT cells present in the decidual tissue are involved in the maintenance of pregnancy in both mice and humans (17, 31) , the spectrum of roles for non-iNKT cells in pregnancy remains to be defined.
This study demonstrates that human decidua was highly enriched for TCRab + CD161 + non-iNKT cells. In contrast to the peripheral blood non-iNKT cells, decidua-residing noniNKT cells had a marked T h 2 bias, preferentially responded to CD1d, and suppress mixed leukocyte reaction (MLR). These findings indicate that decidua-residing non-iNKT cells may play an important role in successful pregnancy by inhibiting fetal rejection and enhancing placental growth.
Methods

Antibodies and reagents
Anti-CD161 (DX12), anti-CD56 (MY31), anti-CD3 (HIT3a), anti-CD28 (CD28.2) mAb and isotype control were obtained from BD PharMingen (San Diego, CA, USA). Anti-Va24 (C15) and anti-Vb11 (C21) mAbs were from Beckman Coulter (Marseille Cedex, France). Anti-TCRab (BMA031) mAb was from Caltag Laboratory (Burlingame, CA, USA). Anti-CD1d (55.3.1) mAb for blocking was kindly provided by Steven A. Porcelli (Albert Einstein College of Medicine, Bronx, NY, USA). CD45RO microbeads and FITC microbeads were obtained from Miltenyi Biotec (Bergisch, Gladbach, Germany). were stimulated with PHA (0.5 lg ml À1 ) and irradiated (4500 cGy) autologous PBMCs. Cells were cultured in RPMI 1640 medium supplement with 10% heat-inactivated human serum, penicillin (100 U ml À1 ), streptomycin (100 lg ml À1 ) and 2 mM L-glutamine (Sigma). Cells were maintained at 37°C in 5% CO 2 in a humidified atmosphere.
EBV-transformed B cell lines
EBV (B95-8) was kindly provided by M. Yasukawa (Ehime University, Ehime, Japan). CD56
À CD161 À cells were isolated from PBMCs by negative magnetic cell sorting using FITCconjugated anti-CD56 mAb, anti-CD161 mAb and FITC microbeads. EBV-transformed B cell lines were established from CD56 À
D161
À cells by in vitro transformation as previously described (32) .
Monocyte-derived dendritic cells
Induction of human monocyte-derived dendritic cells (DCs) was done as described (33) . Further differentiation into mature DCs was induced by treatment with 1 lM prostaglandin E 2 (Sigma) plus 20 ng ml À1 tumor necrosis factor a (Primmune, Osaka, Japan). 
Reverse transcription-PCR
Total RNA was extracted with the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Genomic DNA was digested and removed using an RNase-Free DNase kit (Qiagen). First-strand cDNA was synthesized using oligo (dT) [12] [13] [14] [15] [16] [17] [18] primer (Invitrogen) and the Omniscript RT kit (Qiagen). Synthesized cDNA was subjected to PCR amplification for rearranged TCRa with 29 5#-TCRAV family-specific oligonucleotides (Va1-32) and a 3#-TCRAC (Ca) constant primer and for rearranged TCRb with 27 5#-TCRBV family-specific oligonucleotides (Vb1-25) and a 3#-TCRBC (Cb) constant primer as previously described (33) .
Real-time quantitative reverse transcription-PCR
Transcripts were quantified by real-time quantitative PCR using an ABI PRISM 7900 sequence detector (Perkin-Elmer Applied Biosystems) with Applied Biosystems pre-designed TaqMan Gene Expression Assays and reagents according to the manufacturer's instructions.
Measurement of cytokines
The cytokine levels in the culture supernatants were evaluated with ELISA (R&D Systems, Minneapolis, MN, USA).
Statistical analysis
Statistical analyses were performed using Student's t-test. Values were considered statistically significant at a value of *P < 0.05.
Results
Human decidua is enriched for CD56
+ and CD161 + NKT cells
To determine the frequency and phenotype of NKT cells in the decidua, the expression of NK cell markers by CD3 + T cells obtained from seven decidual tissues (14-21 weeks) was investigated in comparison to matched peripheral blood by flow cytometry. The frequencies of CD56
cells in decidual CD3
+ T cells were much higher than the frequency seen in peripheral blood, while CD56 À CD161 À conventional T cells were much less frequent (Fig. 1A) . Approximately 25-30 and 15% of CD3 + T cells were CD161 + , in decidual tissue and peripheral blood, respectively (Fig. 1B) . Most of the CD3 + T cells were TCRab + both in the decidua and peripheral blood (Fig. 1A) . The frequencies of TCRab + CD161 + T cells were higher than those seen in the peripheral blood. In addition to the high frequency of TCRab + CD161 + NKT cells in the decidua, the high frequency of Va24 + Vb11 + iNKT cells were also detectable in the decidua (0.4-0.7%, data not shown), the frequency were 5-10 times higher than those seen in the peripheral blood. Thereby, decidual T cells were enriched for NKT cells and most of which were TCRab + CD161 + NKT cells. 
CD161
+ NKT cells in the decidua was of maternal origin, as determined by a PCR analysis for the Y-chromosome-specific sequence DYS14 (34) and by a PCR-restriction fragment length polymorphism analysis for the HLA-DR gene (data not shown). To determine whether there is a preferential use of TCRVa-or Vb-chain element by decidual TCRab +
+ NKT cells, we analyzed amplified cDNA using Va-and Vb-specific primers. Although some TCRVa-and Vb-chain elements expressed in decidual TCRab + CD161 + NKT cells differed from those of the peripheral blood in each individual, no consistent pattern emerged among the five individuals tested (Fig. 2B, data not shown). To assess the recognition nature of these TCRs in response to fetal antigens, TCRab + CD161 + NKT cell lines were cultured with EBV-transformed B cell lines with paternal or maternal origin and assayed for proliferation (Fig. 2C) . The proliferative responses of the conventional CD4 + T cells derived from maternal PBMCs to paternal EBV-transformed B cells were higher in magnitude than those from paternal PBMCs. The responses of the paternal CD4
+
+ CD161 + NKT cell lines responded specifically to CD1d-expressing C1R and BeWo transfectants and produced large amounts of IL-4 and IL-10 ( Fig. 3A-D) . There were no such responses to CD1a, b or c transfectants. In contrast, only a trace IFN-c (<150 pg ml ) and IL-2 (0.1 U ml À1 ) as described (35) . The CD1d-specific responses were specifically blocked by anti-CD1d mAb ( Fig. 3C and D) . In contrast to the decidual TCRab + CD161 + NKT cells, the CD1d-specific cytokine production was not detected in peripheral blood TCRab + CD161 + NKT cells (data not shown). To assess the frequency of CD1d-restricted TCRab + CD161 + NKT cells, after depletion of TCRVa24-positive cells, TCRab + CD161 + NKT cells were cloned with a cell sorter and expanded. In total, 5 of 8 from donor 1 and 5 of 11 from donor 2 recognized CD1d-expressing C1R and produced IL-4 and IL-10 but not IFN-c (Fig. 4A-D , data not shown). Four of 10 cloned T cells that responded to CD1d expressed dual TCRVa and a single TCRVb gene transcripts (Fig. 5A and B) . The T h 2-biased cytokine profile was due to the reduced production of IFN-c. This tendency was also observed with PMA/ionomycin stimulation (data not shown). Next, the expressions of T-bet, GATA-3 and Foxp3 in TCRab + CD161 + NKT cell clones (n = 10) from two different individuals were examined by quantitative PCR (Fig. 5C) . In comparison to the peripheral blood TCRab + CD161 + NKT cells, decidual TCRab + CD161 + NKT cells expressed higher levels of GATA-3, but lower T-bet. However, no significant difference was observed in the Foxp3 expression. These findings suggested that decidual TCRab + CD161 + NKT cells are more strongly T h 2 polarized than those of the peripheral blood. 
Decidual
CD161
+ NKT cells suppressed antifetal alloresponses, whereas the decidual Va24 iNKT cells showed no inhibitory effect (Fig. 6A) . To determine the mechanism for the suppression of the anti-fetal alloresponse, we investigated the proliferative response of naive T h in the presence of anti-IL-4, anti-IL-10 or anti-CD1d antibody. The addition of neutralizing anti-IL-4 antibody had little effect on the suppression of proliferation, but the neutralizing anti-IL-10 antibody or the blocking anti-CD1d antibody significantly reversed such suppression (Fig. 6B) . These results indicate that the inhibitory effect of decidual TCRab + CD161 + NKT cells in the MLR was mediated by both CD1d recognition and subsequent IL-10 production.
Discussion
This study demonstrated that a population of CD1d-restricted NKT cells that is distinct from the Va24 iNKT cells accumulates in the decidual tissue, and they can contribute to the maintenance of a T h 2 environment during pregnancy. The CD1d reactivity of decidual NKT cells did not correlate with a particular TCRVa-and Vb-chain usage. The specificity for CD1d was demonstrated by the reduced response to CD1d transfectants in the CD1d blocking and by the failure to respond to CD1a, CD1b or CD1c transfectants. The CD1d expression has been reported in villous and extravillous trophoblasts from the early stages of pregnancy (17, 36) . Therefore, the non-iNKT cells that reside in the decidua may have a functionally important interaction with the trophoblasts that express CD1d molecules.
The presence of a high frequency of non-iNKT cells in the decidua is intriguing because of their ability to rapidly produce large amounts of IL-4 on engagement of the TCRs. This characteristic correlates with the observations that predominantly T h 2 cytokines help the maintenance of pregnancy, and a shift toward a T h 1 cytokine milieu is associated with reproductive failure (37) (38) (39) . In addition, the accumulation of non-iNKT cells in the decidual tissue indicates that these cells are actively recruited to and/or the population is expanded at this site. Although the decidual non-iNKT cells express diverse TCRs, they do not recognize fetal alloantigens. This finding indicates that their accumulation might due to the CD1d expression on trophoblasts rather than the recognition of the fetal antigens. Indeed, it is possible that the pregnancy-associated hormones such as estrogen and progesterone may have various effects on these cells (40) .
The lipid antigens recognized by NKT cells in the maternal-fetal interface have not yet been determined. It has been suggested that monosialoganglioside GM3 (GM3) is a major ganglioside in the placenta and is predominant during the middle stage of pregnancy, while disialoganglioside GD3 (GD3) is expressed in the late stage of gestation (20) . In mouse placenta, the increased expression of an invariant TCRa chain encoded by Va11 and Ja281 gene segments is tightly correlated with the middle stage of gestation when GM3 predominates (24) . In contrast, the TCRVa11 sequence change after which GD3 expression predominates during the late stage of pregnancy. These findings of earlier studies indicate that TCR sequences seem to be associated with changes in the ganglioside composition according to the stage of pregnancy. The initial hypothesis was that the decidual NKT cells may selectively express the limited TCRVa chains, recognize the gangliosides and play a certain role in the pregnancy. Contrary to expectations, the decidual non-iNKT cells do not recognize GM3, GD3 and a-GalCer presented by CD1d. In addition, they do not express a biased TCRVa and Vb gene transcript. Thereby, it is possible that the decidua-residing NKT cells, which express diverse TCRs, may recognize other lipid antigens specifically modified during pregnancy and may play a decisive role in the regulation of maternal-fetal immune responses. It is also possible that the decidual non-iNKT cells expressing different TCRs may recognize sequentially different lipids according to the stage of pregnancy. The endogenous ligands recognized by these T cells are currently under investigation.
The iNKT cells have been reported to develop in the fetus at an early stage of embryogenesis (41) . In addition, the fetal microchimerism can be detected in the maternal circulation (34) . Therefore, it is of great interest to clarify whether the decidua-residing non-iNKT cells are of maternal or fetal origin. The current finding indicates that the non-iNKT cells residing in the decidual tissue are entirely maternally derived. However, the details of the development of this population remain unresolved.
In a recent study, the decidual iNKT cells exhibited a marked T h 1-biased phenotype and a striking polarization toward granulocyte macrophage colony-stimulating factor production (17) . However, the decidual non-iNKT cells herein presented exhibited a clear bias toward IL-4 and IL-10 secretion compared with the peripheral blood non-iNKT cells. As the T h 2 cytokines have been known to stimulate trophoblast outgrowth and invasion (42) (43) (44) , the decidual non-iNKT cells may play an important role in the implantation and trophoblast invasion by producing T h 2 cytokines. The difference in the cytokine production between the deciduaresiding iNKT cells and non-iNKT cells suggests that these distinct populations play different roles in the maintenance of pregnancy.
The CD1 molecules present glycolipids to T cells. Of the five CD1 isoforms identified so far (CD1a, b, c, d and e), all are present in humans, while mice and rats only possess CD1d (45) . This observation indicates that there may be important functional differences between the lipid antigenpresenting milieu in humans and mice. Thereby, exploring the function of decidual non-iNKT cells in several animals would provide important insight into the role of non-iNKT cells for the maintenance of pregnancy.
There are many general adaptations of maternal immune system during pregnancy. The CD4 + CD25 + regulatory T cells are required for maternal immune systems to tolerate fetal allografts. The MLR-suppressing activity observed in decidual non-iNKT cells demonstrates that they may also affect the fetal evasion mechanisms that act locally at the maternal-fetal interface to suppress the anti-fetal response. 
